{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T20:33:21Z","timestamp":1777926801600,"version":"3.51.4"},"reference-count":62,"publisher":"SAGE Publications","issue":"20","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neurotrauma"],"published-print":{"date-parts":[[2015,10]]},"abstract":"<jats:p>Post-traumatic seizures can exacerbate injurious outcomes of severe brain trauma, yet effective treatments are limited owing to the complexity of the pathology underlying the concomitant occurrence of both events. In this study, we tested C\u201010068, a novel deuterium-containing analog of (+)-N-methyl-3-ethoxymorphinan, in a rat model of penetrating ballistic-like brain injury (PBBI) and evaluated the effects of C-10068 on PBBI-induced nonconvulsive seizures (NCS), acute neuroinflammation, and neurofunctional outcomes. NCS were detected by electroencephalographic monitoring. Neuroinflammation was evaluated by immunohistochemical markers, for example, glial fibrillary acidic protein and major histocompatibility complex class I, for activation of astrocytes and microglia, respectively. Neurofunction was tested using rotarod and Morris water maze tasks. Three infusion doses of C-10068 (1.0, 2.5, and 5.0\u2009mg\/kg\/h\u00d772\u2009h) were tested in the antiseizure study. Neuroinflammation and neurofunction were evaluated in animals treated with 5.0\u2009mg\/kg\/h\u00d772\u2009h C-10068. Compared to vehicle treatment, C-10068 dose dependently reduced PBBI-induced NCS incidence (40\u201350%), frequency (20\u201370%), and duration (30\u201382%). The most effective antiseizure dose of C-10068 (5.0\u2009mg\/kg\/h\u00d772\u2009h) also significantly attenuated hippocampal astrocyte activation and perilesional microglial reactivity post-PBBI. Within C-10068-treated animals, a positive correlation was observed in reduction in NCS frequency and reduction in hippocampal astrocyte activation. Further, C-10068 treatment significantly attenuated astrocyte activation in seizure-free animals. However, C-10068 failed to improve PBBI-induced motor and cognitive functions with the dosing regimen used in this study. Overall, the results indicating that C-10068 exerts both potent antiseizure and antiinflammatory effects are promising and warrant further investigation.<\/jats:p>","DOI":"10.1089\/neu.2014.3766","type":"journal-article","created":{"date-parts":[[2015,3,20]],"date-time":"2015-03-20T14:41:40Z","timestamp":1426862500000},"page":"1621-1632","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":18,"title":["Dual Therapeutic Effects of C-10068, a Dextromethorphan Derivative, Against Post-Traumatic Nonconvulsive Seizures and Neuroinflammation in a Rat Model of Penetrating Ballistic-Like Brain Injury"],"prefix":"10.1177","volume":"32","author":[{"given":"Xi-Chun May","family":"Lu","sequence":"first","affiliation":[{"name":"Walter Reed Army Institute of Research"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deborah A.","family":"Shear","sequence":"additional","affiliation":[{"name":"Walter Reed Army Institute of Research"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip B.","family":"Graham","sequence":"additional","affiliation":[{"name":"Concert Pharmaceuticals Inc."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary W.","family":"Bridson","sequence":"additional","affiliation":[{"name":"Concert Pharmaceuticals Inc."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vinita","family":"Uttamsingh","sequence":"additional","affiliation":[{"name":"Concert Pharmaceuticals Inc."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiyong","family":"Chen","sequence":"additional","affiliation":[{"name":"Walter Reed Army Institute of Research"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lai Yee","family":"Leung","sequence":"additional","affiliation":[{"name":"Walter Reed Army Institute of Research"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank C.","family":"Tortella","sequence":"additional","affiliation":[{"name":"Walter Reed Army Institute of Research"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2015,10,15]]},"reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1999.tb05560.x"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1528-1157.44.s10.1.x"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0733-8619(18)30035-5"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.3171\/jns.1998.89.6.0971"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.CCM.0000295667.66853.BC"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000063316.47591.B4"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.55.1.117"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1097\/00001199-200407000-00004"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1053\/apmr.2003.50022"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clineuro.2005.09.001"},{"issue":"1","key":"e_1_3_3_12_2","first-page":"S83","article-title":"Guidelines for the management of severe traumatic brain injury. XIII. Antiseizure prophylaxis","volume":"24","author":"Brain Trauma Foundation; American Association of Neurological Surgeons; Congress of Neurological Surgeons; Joint Section on Neurotrauma and Critical Care, AANS\/CNS","year":"2007","unstructured":"Brain Trauma Foundation; American Association of Neurological Surgeons; Congress of Neurological Surgeons; Joint Section on Neurotrauma and Critical Care, AANS\/CNS, Bratton S.L., , Chestnut R.M., , Ghajar J., , McConnell Hammond F.F., , Harris O.A., , Hartl R., , Manley G.T., , Nemecek A., , Newell D.W., , Rosenthal G., , Schouten J., , Shutter L., , Timmons S.D., , Ullman J.S., , Videtta W., , Wilberger J.E., , and Wright D.W. (2007). Guidelines for the management of severe traumatic brain injury. XIII. Antiseizure prophylaxis. J. Neurotrauma, 24, Suppl. 1, S83\u2013S86.","journal-title":"J. Neurotrauma"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinph.2006.11.312"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1535-7511.2008.00254.x"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.3171\/jns.1999.91.4.0593"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199008233230801"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.3171\/jns.1979.51.4.0507"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1089\/neu.2013.3001"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12028-008-9165-9"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/0165-6147(89)90050-3"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(88)91497-7"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(95)01103-X"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-8993(97)00142-X"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.2165\/00023210-200115070-00005"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1113\/jphysiol.2012.240606"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.2174\/1389450013348335"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1097\/NRL.0b013e3180f60bd8"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-8993(96)00916-X"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0024-3205(97)00132-X"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1007\/s002210050498"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3565(24)35114-6"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0306-4522(97)00322-9"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pbb.2009.07.006"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0024-3205(01)01181-X"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0705998"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3565(25)23652-7"},{"key":"e_1_3_3_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(89)90060-5"},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(88)90350-5"},{"key":"e_1_3_3_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3565(25)39004-X"},{"key":"e_1_3_3_40_2","unstructured":"Uttamsingh V. Nguyen S. Bridson G. Morgan A. and Graham P. (2013). C-10068: a novel sigma agonist morphinan with a superior metabolism and pharmacokinetic profile. Presented at the 10th ISSX International Meeting September 29\u2013October 3 2013 Toronto Ontario Canda."},{"key":"e_1_3_3_41_2","unstructured":"Graham P. Aslanian A. Nguyen S. Uttamsingh V. Morgan A. Bridson G. Sabounjian L. and Shipley S. (2012). C-10068: novel morphinan with a unique pharmacological profile. Presented at Epilepsy Pipeline Meeting February 2\u20134 2012 San Francisco CA."},{"key":"e_1_3_3_42_2","unstructured":"Graham P. (2011). C-10068: novel sigma-1 agonist for epilepsy and neuroprotection. Epilepsy Pipeline Meeting April 27\u201329 2011 Aventara FL."},{"key":"e_1_3_3_43_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-4886(02)00013-4"},{"key":"e_1_3_3_44_2","doi-asserted-by":"publisher","DOI":"10.1089\/neu.2012.2641"},{"key":"e_1_3_3_45_2","doi-asserted-by":"publisher","DOI":"10.1089\/neu.2010.1399"},{"key":"e_1_3_3_46_2","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3940(87)90486-1"},{"key":"e_1_3_3_47_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(87)90070-9"},{"key":"e_1_3_3_48_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0024-3205(02)02309-3"},{"key":"e_1_3_3_49_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.2007.05058.x"},{"key":"e_1_3_3_50_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0701902"},{"key":"e_1_3_3_51_2","doi-asserted-by":"publisher","DOI":"10.2174\/157015908787386113"},{"key":"e_1_3_3_52_2","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(95)02248-1"},{"key":"e_1_3_3_53_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainresrev.2009.10.004"},{"key":"e_1_3_3_54_2","doi-asserted-by":"publisher","DOI":"10.1089\/neu.2013.2965"},{"key":"e_1_3_3_55_2","doi-asserted-by":"publisher","DOI":"10.1038\/jcbfm.2009.109"},{"key":"e_1_3_3_56_2","doi-asserted-by":"publisher","DOI":"10.1089\/neu.2005.22.313"},{"key":"e_1_3_3_57_2","doi-asserted-by":"publisher","DOI":"10.1089\/neu.2006.23.1828"},{"key":"e_1_3_3_58_2","doi-asserted-by":"publisher","DOI":"10.1186\/1742-2094-4-17"},{"key":"e_1_3_3_59_2","doi-asserted-by":"publisher","DOI":"10.3349\/ymj.2008.49.1.1"},{"key":"e_1_3_3_60_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2004.05.004"},{"key":"e_1_3_3_61_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tins.2012.11.008"},{"key":"e_1_3_3_62_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm1277"},{"key":"e_1_3_3_63_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2011.09.033"}],"container-title":["Journal of Neurotrauma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1089\/neu.2014.3766","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/neu.2014.3766","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/neu.2014.3766","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T22:22:07Z","timestamp":1777674127000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1089\/neu.2014.3766"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":62,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["10.1089\/neu.2014.3766"],"URL":"https:\/\/doi.org\/10.1089\/neu.2014.3766","relation":{},"ISSN":["0897-7151","1557-9042"],"issn-type":[{"value":"0897-7151","type":"print"},{"value":"1557-9042","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10]]}}}